CDK4 and glioblastoma: In glioblastoma xenograft models, it has been demonstrated that a combination of CDK4/6is with oncolytic viruses promoted calreticulin exposure and extracellular ATP secretion, which indicated the enlargement of immunologic cell death in glioma cells [92].